Oxford Gene Technology has named Mike Evans director of technical affairs and resource management, and CEO designate. Evans held senior administrative positions at Amersham Biosciences and Ascot Fine Chemicals. Evans holds a BA in Biochemistry, an MA and DPhil from Oxford University. Evans has joined OGT's IP Board and will become the chief executive officer of the OGT group in three months, according to the company
Linda Rubinstein has become vice president and will become chief financial officer of Solexa following the company's filing of its 2004 annual report 10-K form, Hayward, Calif.-based Solexa said yesterday. Kathy San Roman, currently acting CFO, will continue as Solexa's vice president of human resources and administration. Rubinstein used to be a principal of RDJ Advisors, a financial and business operations consulting firm. She holds MA and BA degrees in economics from the University of California, Los Angeles.
Scott DePriest has joined Rosetta Biosoftware as director of business development, the Seattle-based company said last week. Previously, he was director of information business development, sales, and marketing for the Proteome BioKnowledge Library at Incyte Genomics. He also led senior sales management positions at Paracel and Tripos. DePriest holds a PhD in chemistry from the University of Missouri-Rolla and a BA in chemistry from St. Louis University.
Canon last week named Yoroku Adachi president and CEO of Canon USA. Adachi is a 25-year veteran of Canon, and worked at Canon USA from 1978 through 1992, the company said. He has also served as president of Canon Canada, and CEO of Canon China and Canon Hong Kong, and chairman of Canon Singapore. He will replace Kinya Uchida, who had been Canon's top boss in the US since 1999. Canon said Uchida will return to Canon's Tokyo headquarters to work in a new capacity as an advisor. Canon shareholders last week approved the development and sale of DNA chips.